Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
ImmuCell revenue
ImmuCell's revenue is $17.5 million.
What is ImmuCell's revenue?
- ImmuCell's revenue growth from 2014 to 2023 is 130.27%.
- ImmuCell has 67 employees, and the revenue per employee ratio is $260,771.
- ImmuCell's peak quarterly revenue was $7.3M in 2024(q1).
- ImmuCell peak revenue was $19.2M in 2021.
- ImmuCell annual revenue for 2022 was 18.6M, -3.51% growth from 2021.
- ImmuCell annual revenue for 2023 was 17.5M, -5.9% growth from 2022.
On this page
Zippi applies for you, and finds you a job.
ImmuCell historical revenue
ImmuCell annual revenue
ImmuCell annual revenue over time
| Fiscal year / year | ImmuCell revenue |
|---|---|
| 2014 | $7.6M |
| 2015 | $10.2M |
| 2016 | $9.5M |
| 2017 | $10.4M |
| 2018 | $11.0M |
| 2019 | $13.7M |
| 2020 | $15.3M |
| 2021 | $19.2M |
| 2022 | $18.6M |
| 2023 | $17.5M |
Rate ImmuCell's financial transparency
ImmuCell annual growth
ImmuCell annual growth rate over time
| Year | ImmuCell growth |
|---|---|
| 2015 | 35%↑ |
| 2016 | -7%↓ |
| 2017 | 9%↑ |
| 2018 | 6%↑ |
| 2019 | 25%↑ |
| 2020 | 12%↑ |
| 2021 | 25%↑ |
| 2022 | -4%↓ |
| 2023 | -6%↓ |
ImmuCell jobs nearby
Do you work at ImmuCell?
Did ImmuCell meet its revenue projections?
ImmuCell financial information
| CEO | Michael F. Brigham |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 67 |
| Date Founded | 1982 |
| Headquarters | Portland, Maine |
| Number of Locations | 2 |
| Revenue | $17.5M |
| Gross Proft | $3.9M (2023) |
| PE Ratio | -7.36 |
| Tax Rate | -0.0% |
| Market Capitalization | $42.5M |
| Ticker | ICCC |
ImmuCell jobs you might like
ImmuCell financing
ImmuCell received early financing of $3.5M on 2016-10-21.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $3.5M | 10/2016 |
| Post Ipo Debt | $6.5M | 03/2017 |
| Debt Financing | $500K | 01/2020 |
| Post Ipo Equity | $4.3M | 04/2021 |
ImmuCell investors
| Investors | Security type |
|---|---|
| TD Bank | Post Ipo Debt |
| MAINE TECHNOLOGY INSTITUTE | Debt Financing |
ImmuCell competitors
ImmuCell's top competitor, Martek Biosciences, earned an annual revenue of $450.0M.
ImmuCell's smallest competitor is HYCOR Biomedical with revenue of $6.6M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Select Sires | $44,451 | $70.6M | 100 | - |
| Innovacon | $61,477 | $12.1M | 75 | - |
| BioFire Defense | $76,080 | $101.7M | 128 | 3 |
| Martek Biosciences | $71,637 | $450.0M | 600 | - |
| Promega | $72,593 | $450.0M | 1,601 | 31 |
| HYCOR Biomedical | $67,095 | $6.6M | 147 | 5 |
| Medimmune | $78,540 | $422.2M | 6,030 | - |
| MicroPort | $73,160 | $444.2M | 5,000 | 16 |
| CytoSorbents | $82,271 | $35.6M | 160 | 2 |
| Fujirebio Europe | $63,212 | $94.8M | 7,500 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of ImmuCell, including salaries, political affiliations, employee data, and more, in order to inform job seekers about ImmuCell. The employee data is based on information from people who have self-reported their past or current employments at ImmuCell. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by ImmuCell. The data presented on this page does not represent the view of ImmuCell and its employees or that of Zippia.
ImmuCell may also be known as or be related to IMMUCELL CORP DE, ImmuCell, ImmuCell Corp., ImmuCell Corporation and Immucell.